1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for The Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Cancer Biomarkers Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunities

4.1.4.   Challenges

4.2. Technological Landscape

4.3. Regulatory Framework

4.4. Company Market Share Analysis, 2019

4.5. Porter’s Five forces analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Cancer Biomarkers Market Overview

5.1. Market Size & Forecast by Value, 2016-2026

5.1.1.   By Value (USD Billion)

5.2. Market Share & Forecast 2016-2026

5.2.1.   By Type

5.2.1.1.       Protein Biomarker

5.2.1.2.       Genetic Biomarker

5.2.1.3.       Others (cell, viral, and carbohydrate biomarkers)

5.2.2.   By Cancer Type

5.2.2.1.       Breast Cancer

5.2.2.2.       Lung Cancer

5.2.2.3.       Colorectal Cancer

5.2.2.4.       Prostate Cancer

5.2.2.5.       Thyroid Cancer

5.2.2.6.       Bladder Cancer

5.2.2.7.       Kidney Cancer

5.2.2.8.       Others

5.2.3.   By Profiling Technology

5.2.3.1.       Omics Technologies

5.2.3.2.       Imaging Technologies

5.2.3.3.       Immunoassays

5.2.3.4.       Cytogenetics

5.2.3.5.       Bioinformatics

5.2.3.6.       Others

5.2.4.   By Application

5.2.4.1.       Diagnostics

5.2.4.2.       Drug Discovery & Development

5.2.4.3.       Prognostics

5.2.4.4.       Risk Assessment

5.2.4.5.       Others

5.2.5.   By Region

5.2.5.1.       North America

5.2.5.2.       Europe

5.2.5.3.       Asia Pacific

5.2.5.4.       Latin America

5.2.5.5.       Middle East & Africa

6.    North America Cancer Biomarkers Market

6.1. Market Size & Forecast by Value, 2016-2026

6.1.1.   By Value (USD Billion)

6.2. Market Share & Forecast 2016-2026

6.2.1.   By Type

6.2.2.   By Cancer Type

6.2.3.   By Profiling Technology

6.2.4.   By Application

6.2.5.   By Country

6.2.5.1.       U.S

6.2.5.2.       Canada

7.    Europe Cancer Biomarkers Market

7.1. Market Size & Forecast by Value, 2016-2026

7.1.1.   By Value (USD Billion)

7.2. Market Share & Forecast 2016-2026

7.2.1.   By Type

7.2.2.   By Cancer Type

7.2.3.   By Profiling Technology

7.2.4.   By Application

7.2.5.   By Country

7.2.5.1.       Germany

7.2.5.2.       U.K

7.2.5.3.       France

7.2.5.4.       Italy

7.2.5.5.       Rest of Europe

8.    Asia Pacific Cancer Biomarkers Market

8.1. Market Size & Forecast by Value, 2016-2026

8.1.1.   By Value (USD Billion)

8.2. Market Share & Forecast 2016-2026

8.2.1.   By Type

8.2.2.   By Cancer Type

8.2.3.   By Profiling Technology

8.2.4.   By Application

8.2.5.   By Country

8.2.5.1.       China

8.2.5.2.       India

8.2.5.3.       Japan

8.2.5.4.       South Korea

8.2.5.5.       Rest of Asia Pacific

9.    Latin America Cancer Biomarkers Market

9.1. Market Size & Forecast by Value, 2016-2026

9.1.1.   By Value (USD Billion)

9.2. Market Share & Forecast 2016-2026

9.2.1.   By Type

9.2.2.   By Cancer Type

9.2.3.   By Profiling Technology

9.2.4.   By Application

9.2.5.   By Country

9.2.5.1.       Brazil

9.2.5.2.       Mexico

9.2.5.3.       Argentina

9.2.5.4.       Rest of Latin America

10.Middle East & Africa Cancer Biomarkers Market

10.1.             Market Size & Forecast by Value, 2016-2026

10.1.1.                By Value (USD Billion)

10.2.             Market Share & Forecast 2016-2026

10.2.1.                By Type

10.2.2.                By Cancer Type

10.2.3.                By Profiling Technology

10.2.4.                By Application

10.2.5.                By Country

10.2.5.1.    Saudi Arabia

10.2.5.2.    UAE

10.2.5.3.    South Africa

10.2.5.4.    Rest of Middle East & Africa

11.Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

11.1.             Thermo Fisher Scientific

11.2.             Bio-Rad Laboratories

11.3.             Roche Diagnostics

11.4.             Qiagen N.V.

11.5.             Illumina

11.6.             G.E. Healthcare

11.7.             Agilent Technologies

11.8.             Biomérieux SA

11.9.             Merck & Co.

11.10.          Abbott Laboratories

11.11.          Becton, Dickinson, and Company

11.12.          Danaher Corporation

11.13.          Myriad Genetics

11.14.          Sysmex Corporation

11.15.          Hologic

11.16.          Quest Diagnostics

11.17.          Other Prominent Players

 

List of Figures

Fig: Global Cancer Biomarkers Segmentation

Fig: Company Market Share Analysis, 2019

Fig: Global Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Global Cancer Biomarkers Market Share, By Region, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: North America Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: North America Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: North America Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Europe Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Europe Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Europe Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Asia-Pacific Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Latin America Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Latin America Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Latin America Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Size, By Value (USD Billion), 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Y-o-Y Growth, By Value, 2017-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Type, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Cancer Type, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Profiling Technology, By Value, 2016-2026

Fig: Middle-East & Africa Cancer Biomarkers Market Share, By Application, By Value, 2016-2026

Fig: Middle East & Africa Cancer Biomarkers Market Share, By Country, By Value, 2016-2026

 

 

List of Tables:

Table: Global Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Global Cancer Biomarkers Market Size, By Region, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: North America Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Europe Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Asia-Pacific Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Latin America Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Type, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Cancer Type, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Profiling Technology, By Value, 2016-2026

Table: Middle-East & Africa Cancer Biomarkers Market Size, By Application, By Value, 2016-2026

Table: Middle East & Africa Cancer Biomarkers Market Size, By Country, By Value, 2016-2026

Table: Thermo Fisher Scientific Financial Analysis

Table: Bio-Rad Laboratories Financial Analysis

Table: Roche Diagnostics Financial Analysis

Table: Qiagen N.V. Financial Analysis

Table: G.E. Healthcare Financial Analysis

Table: Agilent Technologies Financial Analysis

Table: Biomérieux SA Financial Analysis

Table: Merck & Co. Financial Analysis

Table: Abbott Laboratories Financial Analysis

Table: Danaher Corporation Financial Analysis

 

*Financial Information of non-listed companies will be provided as per the availability

**The segmentation and the companies are subjected to modification based on in-depth secondary for the final deliverable.